title: Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity.
abstract: Doxorubicin continues to be one of the most widely used anticancer agents in the clinic despite its dose-limiting side-effects. Many of doxorubicin's dose-limiting toxicities occur due to its generation of toxic oxygen species, resulting in oxidative stress. Some clinical observations have suggested that doxorubicin may have greater toxicity in older patients. The studies presented here compare basal and doxorubicin-induced antioxidant enzyme activities in brain, heart, kidney and liver tissues of Fisher 344 rats of different ages to determine whether differences in these enzymes can account for the age-dependent differences observed in doxorubicin-induced toxicity. Three groups of animals were tested, young animals (2-months-old), adult animals (10-months-old) and old animals (18-months-old). The results of these studies show that in general young and adult animals have similar levels of antioxidant enzyme activity while the older animals have less. Only in the young animals is antioxidant enzyme activity significantly increased following doxorubicin treatment suggesting that enzyme induction occurs only in the young group of animals. Lipid peroxidation is shown to have the greatest increase in the old animals following doxorubicin treatment while the young animals have the smallest increase. The results from these studies suggest that there is an increase in doxorubicin-induced oxidative damage with age and that these differences may be due to basal and drug-induced differences in tissue antioxidant enzyme activities.
authors.affiliation: Centre for Environmental Science and Engineering, University of Nevada, Mail Stop 199, Reno, NV 89557, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Pritsos
authors.forename: J
authors.initials: J
authors.lastname: Ma
mesh_terms: D000375:Aging; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D000975:Antioxidants / Q000378:metabolism*; D001921:Brain / Q000201:enzymology; D004317:Doxorubicin / Q000633:toxicity*; D004798:Enzymes / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D018384:Oxidative Stress; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants; D004798:Enzymes; D004317:Doxorubicin